Ehsan Jozaghi
TitleCited byYear
A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada
E Jozaghi, AA Reid, MA Andresen
Substance abuse treatment, prevention, and policy 8 (1), 25, 2013
432013
The point of diminishing returns: an examination of expanding Vancouver’s Insite
MA Andresen, E Jozaghi
Urban Studies 49 (16), 3531-3544, 2012
392012
A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada
E Jozaghi, AA Reid, MA Andresen, A Juneau
Substance abuse treatment, prevention, and policy 9 (1), 31, 2014
362014
A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA
A Irwin, E Jozaghi, RN Bluthenthal, AH Kral
Journal of Drug Issues 47 (2), 164-184, 2017
342017
Should North America’s first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?
E Jozaghi, MA Andresen
Harm reduction journal 10 (1), 1, 2013
322013
Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility
A Irwin, E Jozaghi, BW Weir, ST Allen, A Lindsay, SG Sherman
Harm reduction journal 14 (1), 29, 2017
262017
" A little heaven in hell": The role of a supervised injection facility in transforming place
E Jozaghi
Urban Geography 33 (8), 1144-1162, 2012
242012
The role of drug users’ advocacy group in changing the dynamics of life in the Downtown Eastside of Vancouver, Canada
E Jozaghi
Journal of Substance Use 19 (1-2), 213-218, 2014
222014
A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada
E Jozaghi
Harm reduction journal 11 (1), 30, 2014
212014
Peer-engagement and its role in reducing the risky behavior among crack and methamphetamine smokers of the Downtown Eastside community of Vancouver, Canada
E Jozaghi, H Lampkin, MA Andresen
Harm reduction journal 13 (1), 19, 2016
202016
The lessons learned from the fentanyl overdose crises in British Columbia, Canada
E Thomson, H Lampkin, R Maynard, M Karamouzian, E Jozaghi
University of British Columbia, 2017
172017
Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs
E Jozaghi, A Jackson
International journal of health policy and management 4 (6), 373, 2015
162015
Science versus politics: The need for supervised injection facilities in Montreal, Canada
E Jozaghi
International Journal of Drug Policy 5 (23), 420-421, 2012
152012
Exploring the role of an unsanctioned, supervised peer driven injection facility in reducing HIV and hepatitis C infections in people that require assistance during injection
E Jozaghi
Health & justice 3 (1), 16, 2015
112015
Is there a role for potential supervised injection facilities in Victoria, British Columbia, Canada?
E Jozaghi, T Hodgkinson, MA Andresen
Urban Geography 36 (8), 1241-1255, 2015
102015
Activism and scientific research: 20 years of community action by the Vancouver area network of drug users
E Jozaghi, AM Greer, H Lampkin, JA Buxton
Substance abuse treatment, prevention, and policy 13 (1), 18, 2018
92018
Morality versus the scientific evidence: the story behind Bill C-2
E Jozaghi
Journal of Substance Use 21 (3), 225-227, 2016
92016
The role of peer drug users’ social networks and harm reduction programs in changing the dynamics of life for people who use drugs in the downtown eastside of Vancouver, Canada
E Jozaghi
Arts and Social Sciences:, 2015
92015
Back to the core: a network approach to bolster harm reduction among persons who inject drugs
M Bouchard, S Hashimi, K Tsai, H Lampkin, E Jozaghi
International Journal of Drug Policy 51, 95-104, 2018
82018
Missing the trends in the fentanyl overdose crisis: The need for immediate intervention in small and rural communities
E Jozaghi, S Marsh
Canadian Journal of Public Health 108 (4), E457-E457, 2017
82017
The system can't perform the operation now. Try again later.
Articles 1–20